N/A Completed N=81 Randomized Single-blind Treatment

Effectiveness of Intelligent Rehabilitation Robot Training System Combined With Repetitive Facilitative Exercise on Upper Limb Motor Function After Stroke: a Randomized Control Trial.

Source: ClinicalTrials.gov NCT06435624 ↗

Enrolled (actual)

Serious AEs

—

Results posted

Mar 2025

Primary outcomePrimary: Fugl-Meyer Assessment for Upper Extremity (FMA-UE) — 34.4; 34.9; 35.8; 49.0 score on a scale

Summary

The goal of this clinical trial is to learn if intelligent rehabilitation robot training system combined with repetitive facilitative exercise (RFE) work to treat stroke in adults. The main questions it aims to answer are: Does drug intelligent rehabilitation robot training system combined with RFE improve the upper limb motor function of participants? Can the combination of intelligent rehabilitation robot training system and RFE achieve better effects? Researchers will compare 3 groups (RFE, intelligent rehabilitation robot training system under RFE, and conventional therapy) to see if intelligent rehabilitation robot training system and RFE works to treat stroke. Participants will: Receive treatment for 4 weeks Receive scale and instrument testing before and after treatment

Outcome Measures

Outcome	Result	p-value
PRIMARY Fugl-Meyer Assessment for Upper Extremity (FMA-UE)	34.4; 34.9; 35.8; 49.0; 44.2; 38.8	—
PRIMARY Active Participation Proportion	61.7; 104.0; 60.8; 80.4; 61.6; 60.9	—
PRIMARY Trajectory Deviation	104.0; 100.7; 99.5; 65.7; 98.1; 95.7	—
PRIMARY Trajectory Tracking Error	60.8; 60.5; 61.6; 36.8; 58.0; 59.1	—

Eligibility Criteria

Inclusion Criteria

patients (18 to 74 years old) who suffered a first or second unilateral stroke
chronic stroke (over 6 months from the onset)
obvious upper limb movement disorders (FMA-UE scores from 25 to 42)
ability to understand and follow simple directions

Exclusion Criteria

pregnant or lactating
upper extremity contracture, pain, or trauma
perceptual, apraxic, or cognitive deficits that lead to inability to follow verbal instructions
unable to maintain sitting posture
cerebellar lesion
clinically unstable medical disorders
inability to provide informed consent

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT06435624). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.